Nuformix (NFX) Competitors GBX 0.26 -0.02 (-5.36%) As of 10/10/2025 12:21 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsBuy This Stock NFX vs. RLM, NSCI, IXI, OPTI, OBD, FUM, SNG, BVX, TRX, and CIZShould you be buying Nuformix stock or one of its competitors? The main competitors of Nuformix include Realm Therapeutics (RLM), NetScientific (NSCI), IXICO (IXI), OptiBiotix Health (OPTI), Oxford BioDynamics (OBD), Futura Medical (FUM), Synairgen (SNG), BiVictriX Therapeutics (BVX), Tissue Regenix Group (TRX), and Cizzle Biotechnology (CIZ). These companies are all part of the "biotechnology" industry. Nuformix vs. Its Competitors Realm Therapeutics NetScientific IXICO OptiBiotix Health Oxford BioDynamics Futura Medical Synairgen BiVictriX Therapeutics Tissue Regenix Group Cizzle Biotechnology Nuformix (LON:NFX) and Realm Therapeutics (LON:RLM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations. Do insiders & institutionals hold more shares of NFX or RLM? 0.1% of Nuformix shares are owned by institutional investors. 11.2% of Nuformix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, NFX or RLM? Realm Therapeutics has higher revenue and earnings than Nuformix. Nuformix is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuformixN/AN/A-£383.40K-£0.00-66.25Realm Therapeutics£501.92K0.00N/A-£17.50N/A Is NFX or RLM more profitable? Realm Therapeutics' return on equity of 0.00% beat Nuformix's return on equity.Company Net Margins Return on Equity Return on Assets NuformixN/A -5.68% -17.20% Realm Therapeutics N/A N/A N/A Do analysts prefer NFX or RLM? Nuformix presently has a consensus price target of GBX 293, suggesting a potential upside of 110,466.04%. Given Nuformix's stronger consensus rating and higher possible upside, analysts plainly believe Nuformix is more favorable than Realm Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuformix 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Realm Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer NFX or RLM? In the previous week, Nuformix had 1 more articles in the media than Realm Therapeutics. MarketBeat recorded 1 mentions for Nuformix and 0 mentions for Realm Therapeutics. Nuformix's average media sentiment score of 0.00 equaled Realm Therapeutics'average media sentiment score. Company Overall Sentiment Nuformix Neutral Realm Therapeutics Neutral SummaryNuformix beats Realm Therapeutics on 7 of the 11 factors compared between the two stocks. Get Nuformix News Delivered to You Automatically Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NFX vs. The Competition Export to ExcelMetricNuformixBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.59M£153.71M£6.11B£2.52BDividend YieldN/A3.81%5.67%5.30%P/E Ratio-66.2595.4685.354,387.87Price / SalesN/A6,044.17613.06100,188.31Price / Cash3.5513.1938.5027.90Price / Book0.49109.9012.748.19Net Income-£383.40K-£90.99M£3.30B£5.89B7 Day Performance10.42%0.09%0.82%-0.20%1 Month Performance126.50%5.43%6.22%2.29%1 Year PerformanceN/A718.58%80.30%145.58% Nuformix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NFXNuformix1.3399 of 5 starsGBX 0.27-5.4%GBX 293+110,466.0%+373.2%£5.59MN/A-66.253News CoverageGap DownRLMRealm TherapeuticsN/AN/AN/AN/A£13.41M£501.92K-0.66N/ANSCINetScientificN/AN/AN/AN/A£12.81M£1.45M-486.3626IXIIXICON/AGBX 12-9.4%N/A+26.3%£11.12M£6.44M-515.0289High Trading VolumeOPTIOptiBiotix HealthN/AGBX 10.55-4.1%N/A-26.5%£10.90M£1.15M-573.481Positive NewsOBDOxford BioDynamicsN/AGBX 0.53-4.5%N/A-85.8%£10.28M£896K-18.1045Analyst ForecastGap UpFUMFutura MedicalN/AGBX 3.30-6.3%N/A-92.6%£10.03M£13.93M804.8812Gap DownSNGSynairgenN/AN/AN/AN/A£9.04MN/A-0.5634Gap DownBVXBiVictriX TherapeuticsN/AN/AN/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeTRXTissue Regenix GroupN/AGBX 10.50flatN/A-85.6%£7.48M£28.65M-1,050.00120Gap UpHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.29-8.0%N/A-28.6%£5.11MN/A-214.674Gap Down Related Companies and Tools Related Companies RLM Alternatives NSCI Alternatives IXI Alternatives OPTI Alternatives OBD Alternatives FUM Alternatives SNG Alternatives BVX Alternatives TRX Alternatives CIZ Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NFX) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuformix plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuformix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
